• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.63% Nasdaq Up 0.40%

    More On SKP.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Skyepharma PLC (SKP.L)

    -LSE
    378.00 Up 4.75(1.27%) 9:33AM EST
    Prev Close:373.25
    Open:365.00
    Bid:375.00 x 32500
    Ask:376.50 x 25200
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:365.00 - 380.62
    52wk Range:249.25 - 414.45
    Volume:19,262
    Avg Vol (3m):171,209
    Market Cap:395.84M
    P/E (ttm):24.39
    EPS (ttm):15.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):0.19
    P/S (ttm):487.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :21.07
    Quarterly EPS Est (Dec-15) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Skyepharma PLC develops and sells oral and inhalation pharmaceutical products. The company’s inhalation products include flutiform, a multi-dose pressurized metered dose inhaler for the treatment of bronchial asthma; Anoro Ellipta and Incruse... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback